Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-5-4
pubmed:abstractText
Activation of the immune system and abnormal growth of skin fibroblasts cause systemic sclerosis. Growth factors have various biological activities, including mediation of immune reactions. The growth factor family includes basic fibroblast growth factor (bFGF), transforming growth factor-beta (TGF-beta), and connective tissue growth factor (CTGF). CTGF, an important downstream mediator of TGF-beta in fibrosis, has been suggested to play a specific role in fibrotic disorders. We have directed our attention to the role of CTGF in sustaining skin fibrosis. To better understand its effects in vivo, we established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, bFGF transiently induced subcutaneous fibrosis. Simultaneous injection of bFGF and CTGF increased skin fibrosis compared with a single injection of bFGF. Serial injections of bFGF for 3 days followed by CTGF for 4 days, or of CTGF followed by bFGF, did not cause skin fibrosis but simultaneous injections increased macrophage chemoattractant protein-1 (MCP-1) mRNA expression levels. To further define the mechanisms of skin fibrosis in vivo, bFGF and CTGF were injected simultaneously into MCP-1 knockout mice, resulting in decreased collagen levels in granulation tissues on day 8. The number of inflammatory cells, such as mast cells, macrophages and lymphocytes, was significantly decreased in MCP-1 knockout mice compared with wild-type mice. These results suggest that bFGF induces collagen production by stimulating skin fibroblasts and CTGF cooperates with bFGF. Our results indicate that the induction of MCP-1 is necessary for infiltration of inflammatory cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1097-4652
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
220
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
189-95
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19277979-Animals, pubmed-meshheading:19277979-Cell Movement, pubmed-meshheading:19277979-Chemokine CCL2, pubmed-meshheading:19277979-Collagen, pubmed-meshheading:19277979-Collagen Type I, pubmed-meshheading:19277979-Connective Tissue Growth Factor, pubmed-meshheading:19277979-Disease Models, Animal, pubmed-meshheading:19277979-Fibroblast Growth Factor 2, pubmed-meshheading:19277979-Fibroblasts, pubmed-meshheading:19277979-Fibrosis, pubmed-meshheading:19277979-Granulation Tissue, pubmed-meshheading:19277979-Humans, pubmed-meshheading:19277979-Injections, Subcutaneous, pubmed-meshheading:19277979-Mice, pubmed-meshheading:19277979-Mice, Inbred C57BL, pubmed-meshheading:19277979-Mice, Knockout, pubmed-meshheading:19277979-RNA, Messenger, pubmed-meshheading:19277979-Scleroderma, Systemic, pubmed-meshheading:19277979-Skin, pubmed-meshheading:19277979-Skin Diseases, pubmed-meshheading:19277979-Time Factors
pubmed:year
2009
pubmed:articleTitle
Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis.
pubmed:affiliation
Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan.
pubmed:publicationType
Journal Article